Italia markets closed

Exact Sciences Corporation (EXAS)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
43,91+1,20 (+2,81%)
Al 02:31PM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente42,71
Aperto42,64
Denaro43,90 x 800
Lettera43,90 x 900
Min-Max giorno42,52 - 44,01
Intervallo di 52 settimane35,34 - 108,99
Volume1.066.968
Media Volume2.115.341
Capitalizzazione7,77B
Beta (5 anni mensile)1,32
Rapporto PE (ttm)N/D
EPS (ttm)-4,32
Prossima data utili31 ott 2022 - 04 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A71,63
  • GlobeNewswire

    Diversey Appoints Katherine S. Zanotti to its Board of Directors

    FORT MILL, S.C., March 01, 2022 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, has appointed Katherine S. Zanotti to the company’s board of directors, effective March 1, 2022. This appointment will bring the total number of directors to eleven. “We are delighted to welcome Katherine (‘Kay’) to our board. Kay’s long history of leadership coupled with her extensive experience in sales and marketing within the

  • GlobeNewswire

    Renalytix Appoints Daniel J. Levangie to its Board of Directors

    Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and HologicNEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr. Levangie is also appointed as a member of the Company’s remuneration committee. Mr. Levangie is an experienced executive and long-serving board director in the di